4 completed. 3 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 3 | Completed 3 |
| Phase 2 | 1 | Completed 1 |
Follow L-Phenylalanine: new trials by email Literature Review of L-Phenylalanine trials Research Report on L-Phenylalanine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phe for Me? The Effects of L-Phe on PKU Carriers and Non-carriers L-Phenylalanine - Autosomal Recessive Disorder (Genetic Carriers of PKU) | Not applicable | Completed | University of Guelph | 56 | 2024-06-18 | 2026-05-04 |
| PKU Carriers Trial (Pilot Study): Impact on Cognition, Mental Health, Blood Pressure and Metabolism L-Phenylalanine - Autosomal Recessive Disorder (Genetic Carriers of PKU) | Not applicable | Completed | University of Guelph | 7 | 2023-07-01 | 2024-12-06 |
| Mechanistic Approach to Preventing Atrophy and Restoring Function in Older Adults Essential Amino Acids (EAA), Placebo (Alanine) - Muscle Atrophy, Quality of Life | Phase 2 | Completed | University of Oregon | 80 | 2014-12-01 | 2024-07-23 |
| Estrogen and Serotonin on Changing Brain Chemistry estrogen patch, Amino acids, Placebo Patch - Menopause | Not applicable | Completed | University of Colorado, Denver | 47 | 2010-03-04 | 2021-04-02 |
Memory Disorders (1) · Muscular Atrophy (1)
University of Guelph (2) · University of Colorado, Denver (1) · University of Oregon (1)
Canada (2) · United States (2)
Cynthia Neill Epperson, M.D. (1)
PMID 26733251, PMID 26829246, PMID 30280129, PMID 31343947, PMID 41555437
P50MH099910 (1), R01AG046401 (1)